Silent Mutations Reveal a Novel Treatment for RASQ61 Cancers

Skip to Main Content

Skip Nav Destination

Article navigation

Research Watch| May 02 2022

Silent Mutations Reveal a Novel Treatment for RAS^Q61 Cancers

Online Issn: 2159-8290

Print Issn: 2159-8274

2022

American Association for Cancer Research

Cancer Discov (2022) 12 (5): OF9.

Silent mutations are needed for functional KRAS^Q61K and revealed exonic splicing enhancer (ESE) motif enhancement around RAS^Q61.

2022

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.